Skip to main content

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, usually called CADASIL, is an inherited condition that causes stroke and other impairments. This condition affects blood flow in small blood vessels, particularly cerebral vessels within the brain. The muscle cells surrounding these blood vessels (vascular smooth muscle cells) are abnormal and gradually die. In the brain, the resulting blood vessel damage (arteriopathy) can cause migraines, often with visual sensations or auras, or recurrent seizures (epilepsy).

Description

Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy, usually called CADASIL, is an inherited condition that causes stroke and other impairments. This condition affects blood flow in small blood vessels, particularly cerebral vessels within the brain. The muscle cells surrounding these blood vessels (vascular smooth muscle cells) are abnormal and gradually die. In the brain, the resulting blood vessel damage (arteriopathy) can cause migraines, often with visual sensations or auras, or recurrent seizures (epilepsy).

Damaged blood vessels reduce blood flow and can cause areas of tissue death (infarcts) throughout the body. An infarct in the brain can lead to a stroke. In individuals with CADASIL, a stroke can occur at any time from childhood to late adulthood, but typically happens during mid-adulthood. People with CADASIL often have more than one stroke in their lifetime. Recurrent strokes can damage the brain over time. Strokes that occur in the subcortical region of the brain, which is involved in reasoning and memory, can cause progressive loss of intellectual function (dementia) and changes in mood and personality.

Many people with CADASIL also develop leukoencephalopathy, which is a change in a type of brain tissue called white matter that can be seen with magnetic resonance imaging (MRI).

The age at which the signs and symptoms of CADASIL first begin varies greatly among affected individuals, as does the severity of these features.

CADASIL is not associated with the common risk factors for stroke and heart attack, such as high blood pressure and high cholesterol, although some affected individuals might also have these health problems.

Inheritance patterns

The source lists the following possible inheritance patterns: Autosomal dominant. More than one pattern can apply in different cases.

Other names

CADASIL

Cerebral arteriopathy with subcortical infarcts and leukoencephalopathy

Familial vascular leukoencephalopathy

Hereditary dementia, multi-infarct type

Patient picks for Genetic conditions

Related patient information and medicines

Marfan syndrome

Patient information leaflet

Marfan syndrome

Marfan syndrome (named after Dr Antoine Marfan, the French doctor who first described it in 1896) is a genetic disorder which people are born with and which lasts lifelong. Marfan syndrome can affect the connective tissue in different parts of your body, including your heart, blood vessels, eyes and skeleton. It is an autosomal dominant condition,.

Subarachnoid haemorrhage

Patient information leaflet

Subarachnoid haemorrhage

A subarachnoid haemorrhage (SAH) is a form of stroke in which bleeding occurs into the fluid-filled space surrounding the brain (called the subarachnoid space). It is usually caused by the rupture of a small berry-like swelling (called a berry aneurysm) on one of the arteries in the brain. Certain inherited conditions which cause weakening of the.

CT scan

Patient information leaflet

CT scan

Note : the information below is a general guide only. The arrangements, and the way tests are performed, may vary between different hospitals. It also gives clear pictures of soft tissues, whi... The most commonly performed CT scan is of the brain - to determine the cause of a stroke Stroke , or to assess serious head injuries. Other uses of a CT.

Nasal congestion

Patient information leaflet

Nasal congestion

There have been rare reports of two conditions associated with pseudoephedrine use - posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstri... Following a review by MHRA - the safety information of all pseudoephedrine-containing medicines will be updated to provide clearer descriptions of these risks and potential.

Diabetic kidney disease

Patient information leaflet

Diabetic kidney disease

Diabetic kidney disease is a complication that occurs in some people with diabetes. Also, it aims to reduce the risk of developing cardiovascular diseases such as heart attack and stroke which are much more common than average in people with this disease. Cardiovascular diseases All people with diabetes have an increased risk of developing.

Decongestants

Patient information leaflet

Decongestants

Dr Krishna Vakharia , 21st February 2024 A note on pseudoephedrine-containing products. The Medicines and ... There have been rare reports of two conditions associated with pseudoephedrine use - posterior reversible encephalopathy syndrome (PRES) and reversible cerebral vasoconstriction syndrome (RCVS). PRES- also known as reversible posterior.

Further reading and references

Article history

The information on this page is written and peer reviewed by qualified clinicians.
  • 18 Aug 2020 | Latest version
  • 1 May 2008 | Originally published

Join the conversation

Share your thoughts or experiences with others in our patient communities.

Disclaimer: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Online pharmacy, treatments and health services

Simple access to trusted treatments and health services online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Sign up to the Patient newsletter

Your weekly dose of clear, trustworthy health advice - written to help you feel informed, confident and in control.

Please enter a valid email address

By subscribing you accept our Privacy Policy. You can unsubscribe at any time. We never sell your data.